SI
DGX icon

Sapience Investments’s Quest Diagnostics DGX Stock Holding History

Sapience Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,725
Closed -$1.69M – 89
2020
Q3 		$1.69M Buy
14,725
+4,250
+41% +$502K 0.3% 80
2020
Q2 		$1.19M Sell
10,475
-11,345
-52% -$1.2M 0.22% 90
2020
Q1 		$1.75M Sell
21,820
-8,200
-27% -$849K 0.39% 81
2019
Q4 		$3.21M Sell
30,020
-50
-0.2% -$5.21K 0.45% 69
2019
Q3 		$3.22M Buy
30,070
+160
+0.5% +$16.4K 0.45% 71
2019
Q2 		$3.04M Buy
29,910
+1,570
+6% +$151K 0.41% 76
2019
Q1 		$2.55M Buy
+28,340
New +$2.46M 0.34% 79

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sapience Investments's DGX Position: Q4 2020 in Review

Sapience Investments sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 14,725 shares — an estimated $1.69M sold.

Sapience Investments first reported a position in DGX in Q1 2019 and held it in 7 quarters. The position peaked at $3.22M in Q3 2019. 811 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

  • Sapience Investments reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Sapience Investments sold 14,725 Quest Diagnostics shares in Q4 2020, an estimated $1.69M.
  • Sapience Investments first reported a position in Quest Diagnostics in Q1 2019 and held it in 7 quarters.
  • Sapience Investments's Quest Diagnostics position peaked at $3.22M in Q3 2019.
  • 811 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on Sapience Investments's 13F filing for Q4 2020, filed 16 Feb 2021.